| News
docdok.health involved in coronavirus research project
22.02.2021
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

img: docdok.health
According to a media release, the new research project on the effects of coronavirus infection has been launched by the CAir Konsortium, which includes the University Hospital Zurich (USZ) and the Swiss Federal Institute of Technology in Zurich (ETH) in addition to docdok.health, among others. The media release from docdok.health states that the project is also being supported by AstraZeneca Switzerland. With this, the research partners hope to investigate “the improvement in symptoms, lung function and quality of life in persons who have been hospitalized due to a coronavirus (specifically SARS-CoV-2) infection and the related severe lung disease to lung failure.”
For this, patients were surveyed after being discharged from the USZ using a docdok.health smartphone app, and a home monitoring system was implemented to follow-up patients. This system consists of “a lung function measuring device, an activity wristband, an air quality monitor, and a smartphone.” This system, called CAir Desk, was originally developed for the long-term care of patients with chronic lung disease.
Physicians from the USZ are able to study the data from both approaches at their place of work. For this, the data is prepared by docdok.health and presented clearly on an appropriate user interface. The company based in Basel was founded in 2017 and develops solutions to drive forward utility-based healthcare. The platform they have developed can collect and prepare patient-generated health data. This platform is already in use in five countries both for routine clinical applications and studies.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
BLKB supporting startups in Basel region
Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...
Read MoreBioVersys receives funding in the fight against tuberculosis
The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...
Read MoreBiosynex takes up residence in Delémont
The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for COVID-19. It has...
Read MoreNovartis Campus opening further
Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...
Read Moredocdok.health increases safety of coronavirus vaccinations
The Basel-based start-up docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...
Read MoreHemex attracts Swiss investors
A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...
Read More